Officials’ Apathy Allows Quackery To Flourish: Delhi’s ‘Salman Bhai’ Runs Paid ‘Herbal Cure’ Camp For Incurable Alopecia In Mughalsarai
Department Of Commerce Organizes Chintan Shivir To Strengthen India’s Medical Devices Export Ecosystem
Domestic MedTech gets shot in the arm with First Fund launched
Minor Girl Hospitalised After Allegedly Consuming Cough Syrup In Raebareli
Supreme Court declines plea to make nucleic acid tests compulsory at blood banks
Jaipur: Fraudster Arun Kumar Arrested for Extorting Medical Store Owners by Posing as Drug Inspector
India’s Medical Devices Sector Logs 4,108 Licensed Manufacturers and ₹20,658 Crore FDI Inflows Since 2018
Abbott introduces its most advanced drug eluting stent XIENCE Skypoint™ in India
Top 30 pharma companies post 12% revenue growth in first nine months
India Cracks Down On Ads For Weight-Loss Drugs Like GLP-1 In New Advisory
Small-cap pharma stock Sigachi Industries jumps after CARE reaffirms credit rating
Small-cap pharma stock Sigachi Industries gained over 2 per cent in intra-day trade on Friday, January 3, after CARE Ratings reaffirmed its rating action on the company. In an exchange filing on…
Kwality Pharma gains on securing RCGM approval for Erythropoietin
Kwality Pharmaceuticals rose 3.19% to Rs 895 after the company secured approval from the Review Committee on Genetic Manipulation (RCGM) to begin pre-clinical toxicity studies for the recombinant Erythropoietin product,…
Man held with drugs worth Rs 2.50 cr, planned for New Year supply in Bengaluru
Bengaluru: A man has been arrested for allegedly storing drugs worth Rs 2.50 crore, meant for distribution during the new year celebrations in prominent areas of Bengaluru. The arrest was…
Sun Pharma sells entire stake in Japanese arm to Zaza Industrial Holdings
Sun Pharmaceutical Industries has announced the 100 per cent sale of its step-down subsidiary, Sun Pharma Japan Technical Operations, to Zaza Industrial Holdings K.K., Japan. The decision marks a strategic…
Bliss GVS Pharma Reaches 52-Week High of Rs. 181.35 with 42.53% Annual Return
Bliss GVS Pharma, a small-cap player in the pharmaceuticals and drugs industry, has recently reached a new 52-week high of Rs. 181.35 on January 1, 2025. The stock has shown…
New Pharma Rules In India Effective Today: Are MSMEs Ready? What Will Change For The Industry
New Delhi: The drug companies in India will now have to meet the standard specified in the revised schedule M – as the new rules come into effect, starting today,…
Sun Pharma To Sell 100 Percent Stake In Japanese Arm
Mumbai: Sun Pharmaceutical Industries Limited has entered into an agreement with Zaza Industrial Holdings K.K, Japan, under which Sun Pharma has agreed to sell 100% shares held in Sun Pharma…
Spurious drugs worth around Rs 6.6 crore seized from Kolkata wholesale firm
Drugs worth around Rs 6.6 crore, suspected to be spurious, have been seized from a wholesale firm in Kolkata in a joint operation by the Central Drugs Standard Control Organisation…
NPPA hauled up for hiking drug prices
New Delhi: The parliamentary standing committee on chemicals and fertilisers has pulled up India’s drug pricing regulator for approving a 50% price hike on 11 drug formulations in October, saying…
2025 Outlook: Will pharma sector get a shot in its arm in 2025?
Predictions for 2025: Pharma and healthcare mutual funds have offered the highest average return of around 38.05% in 2024 (from January 1, 2024 to December 3, 2024), as per an…
